Industry Research Reports
Home > Reports > Service & Software > Global Drug Repositioning Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Drug Repositioning Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Service & Software
Published Date: 2025-09-10
Pages: 96 Pages
Report ld: 4709874
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Drug Repositioning Market Size(US$)
CAGR 2025-2031
4.7%
Market Size,2031
USD 40,830
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 30,990 million
Market Forecast in 2031(Value)
US$ 40,830 million
CAGR
4.7%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Drug Repositioning market size was US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 40830 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
The drug repositioning market is driven by the growing demand for cost-effective and time-saving drug development strategies. Traditional drug discovery can take over a decade and cost billions of dollars, with a high risk of failure during clinical trials. Repositioning, on the other hand, allows pharmaceutical companies to repurpose known drugs with existing safety and pharmacokinetic profiles, thereby accelerating time to market and reducing development risk. This approach is especially appealing for rare diseases, cancer, and neurodegenerative disorders where treatment options are limited. Additionally, advances in data mining, artificial intelligence, and systems biology have improved the ability to identify new drug-disease relationships, fueling further interest. Regulatory agencies such as the FDA and EMA also support repositioning by offering faster review pathways and incentives for orphan indications, making this strategy increasingly viable from a business perspective.
Despite its advantages, the drug repositioning market faces several challenges. One of the major issues is intellectual property protection—many repositioned drugs are off-patent, making it difficult for companies to secure exclusivity and justify investment. In cases where patent life can be extended through new formulations or uses, legal and regulatory hurdles still exist. Another challenge lies in clinical validation; while safety data may already be available, proving efficacy for a new indication still requires substantial clinical trial investment. Moreover, the lack of centralized, standardized databases for repositioning candidates limits discovery efficiency. The fragmented nature of available data—spread across academic publications, clinical trial registries, and real-world evidence—makes it hard to integrate and analyze comprehensively. Finally, collaboration between industry and academia, which is crucial for repositioning, is often hindered by misaligned goals and timelines.
The global Drug Repositioning market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Teva
- Novartis
- Mylan
- Johnson & Johnson
- Pfizer
- Bausch Health
- GSK
- ChemRar Group
- Glenmark
- Fujifilm
- Dr. Reddy
- R-Pharma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Generic Drugs
- Clinical Trial Failed Drugs
Segment by Application
- Cardiovascular Diseases
- Mental Illness
- Cancer
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Drug Repositioning market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Clinical Trial Failed Drugs in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Mental Illness in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drug Repositioning value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Repositioning Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Drug Repositioning Revenue Market Share by Region (2020-2025)
2.4 Global Drug Repositioning Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Drug Repositioning Market Size and Prospective (2020-2031)
2.5.2 Europe Drug Repositioning Market Size and Prospective (2020-2031)
2.5.3 China Drug Repositioning Market Size and Prospective (2020-2031)
2.5.4 Japan Drug Repositioning Market Size and Prospective (2020-2031)
2.5.5 Southeast Aisa Drug Repositioning Market Size and Prospective (2020-2031)
2.5.6 India Drug Repositioning Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Drug Repositioning Historic Market Size by Type (2020-2025)
3.2 Global Drug Repositioning Forecasted Market Size by Type (2026-2031)
3.3 Different Types Drug Repositioning Representative Players
4 Breakdown Data by Application
4.1 Global Drug Repositioning Historic Market Size by Application (2020-2025)
4.2 Global Drug Repositioning Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Drug Repositioning Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Drug Repositioning Players by Revenue (2020-2025)
5.1.2 Global Drug Repositioning Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Drug Repositioning Revenue
5.4 Global Drug Repositioning Market Concentration Analysis
5.4.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Revenue in 2024
5.5 Global Key Players of Drug Repositioning Head office and Area Served
5.6 Global Key Players of Drug Repositioning, Product and Application
5.7 Global Key Players of Drug Repositioning, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Drug Repositioning Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Drug Repositioning Market Size by Type (2020-2025)
6.1.2.2 North America Drug Repositioning Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Drug Repositioning Market Size by Application (2020-2025)
6.1.3.2 North America Drug Repositioning Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Drug Repositioning Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Drug Repositioning Market Size by Type (2020-2025)
6.2.2.2 Europe Drug Repositioning Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Drug Repositioning Market Size by Application (2020-2025)
6.2.3.2 Europe Drug Repositioning Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Drug Repositioning Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Drug Repositioning Market Size by Type (2020-2025)
6.3.2.2 China Drug Repositioning Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Drug Repositioning Market Size by Application (2020-2025)
6.3.3.2 China Drug Repositioning Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Drug Repositioning Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Drug Repositioning Market Size by Type (2020-2025)
6.4.2.2 Japan Drug Repositioning Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Drug Repositioning Market Size by Application (2020-2025)
6.4.3.2 Japan Drug Repositioning Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Aisa Market: Players, Segments and Downstream
6.5.1 Southeast Aisa Drug Repositioning Revenue by Company (2020-2025)
6.5.2 Southeast Aisa Market Size by Type
6.5.2.1 Southeast Aisa Drug Repositioning Market Size by Type (2020-2025)
6.5.2.2 Southeast Aisa Drug Repositioning Market Share by Type (2020-2025)
6.5.3 Southeast Aisa Market Size by Application
6.5.3.1 Southeast Aisa Drug Repositioning Market Size by Application (2020-2025)
6.5.3.2 Southeast Aisa Drug Repositioning Market Share by Application (2020-2025)
6.5.4 Southeast Aisa Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Drug Repositioning Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Drug Repositioning Market Size by Type (2020-2025)
6.6.2.2 India Drug Repositioning Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Drug Repositioning Market Size by Application (2020-2025)
6.6.3.2 India Drug Repositioning Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Teva
7.1.1 Teva Company Details
7.1.2 Teva Business Overview
7.1.3 Teva Drug Repositioning Introduction
7.1.4 Teva Revenue in Drug Repositioning Business (2020-2025)
7.1.5 Teva Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Drug Repositioning Introduction
7.2.4 Novartis Revenue in Drug Repositioning Business (2020-2025)
7.2.5 Novartis Recent Development
7.3 Mylan
7.3.1 Mylan Company Details
7.3.2 Mylan Business Overview
7.3.3 Mylan Drug Repositioning Introduction
7.3.4 Mylan Revenue in Drug Repositioning Business (2020-2025)
7.3.5 Mylan Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Details
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Drug Repositioning Introduction
7.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2020-2025)
7.4.5 Johnson & Johnson Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Details
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Drug Repositioning Introduction
7.5.4 Pfizer Revenue in Drug Repositioning Business (2020-2025)
7.5.5 Pfizer Recent Development
7.6 Bausch Health
7.6.1 Bausch Health Company Details
7.6.2 Bausch Health Business Overview
7.6.3 Bausch Health Drug Repositioning Introduction
7.6.4 Bausch Health Revenue in Drug Repositioning Business (2020-2025)
7.6.5 Bausch Health Recent Development
7.7 GSK
7.7.1 GSK Company Details
7.7.2 GSK Business Overview
7.7.3 GSK Drug Repositioning Introduction
7.7.4 GSK Revenue in Drug Repositioning Business (2020-2025)
7.7.5 GSK Recent Development
7.8 ChemRar Group
7.8.1 ChemRar Group Company Details
7.8.2 ChemRar Group Business Overview
7.8.3 ChemRar Group Drug Repositioning Introduction
7.8.4 ChemRar Group Revenue in Drug Repositioning Business (2020-2025)
7.8.5 ChemRar Group Recent Development
7.9 Glenmark
7.9.1 Glenmark Company Details
7.9.2 Glenmark Business Overview
7.9.3 Glenmark Drug Repositioning Introduction
7.9.4 Glenmark Revenue in Drug Repositioning Business (2020-2025)
7.9.5 Glenmark Recent Development
7.10 Fujifilm
7.10.1 Fujifilm Company Details
7.10.2 Fujifilm Business Overview
7.10.3 Fujifilm Drug Repositioning Introduction
7.10.4 Fujifilm Revenue in Drug Repositioning Business (2020-2025)
7.10.5 Fujifilm Recent Development
7.11 Dr. Reddy
7.11.1 Dr. Reddy Company Details
7.11.2 Dr. Reddy Business Overview
7.11.3 Dr. Reddy Drug Repositioning Introduction
7.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2020-2025)
7.11.5 Dr. Reddy Recent Development
7.12 R-Pharma
7.12.1 R-Pharma Company Details
7.12.2 R-Pharma Business Overview
7.12.3 R-Pharma Drug Repositioning Introduction
7.12.4 R-Pharma Revenue in Drug Repositioning Business (2020-2025)
7.12.5 R-Pharma Recent Development
8 Drug Repositioning Market Dynamics
8.1 Drug Repositioning Industry Trends
8.2 Drug Repositioning Market Drivers
8.3 Drug Repositioning Market Challenges
8.4 Drug Repositioning Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Drug Repositioning Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drug Repositioning Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Drug Repositioning Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Drug Repositioning Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Drug Repositioning Revenue Share by Region (2020-2025)
Table 6. Global Drug Repositioning Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Drug Repositioning Revenue Share Forecast by Region (2026-2031)
Table 8. Global Drug Repositioning Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Drug Repositioning Revenue Market Share by Type (2020-2025)
Table 10. Global Drug Repositioning Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Drug Repositioning Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Drug Repositioning Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Drug Repositioning Revenue Market Share by Application (2020-2025)
Table 15. Global Drug Repositioning Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Drug Repositioning Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Drug Repositioning Application
Table 18. Global Drug Repositioning Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Drug Repositioning Market Share by Players (2020-2025)
Table 20. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2024)
Table 21. Ranking of Global Top Drug Repositioning Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Drug Repositioning Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Drug Repositioning, Headquarters and Area Served
Table 24. Global Key Players of Drug Repositioning, Product and Application
Table 25. Global Key Players of Drug Repositioning, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Drug Repositioning Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Drug Repositioning Revenue Market Share by Company (2020-2025)
Table 29. North America Drug Repositioning Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Drug Repositioning Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Drug Repositioning Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Drug Repositioning Revenue Market Share by Company (2020-2025)
Table 33. Europe Drug Repositioning Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Drug Repositioning Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Drug Repositioning Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Drug Repositioning Revenue Market Share by Company (2020-2025)
Table 37. China Drug Repositioning Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Drug Repositioning Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Drug Repositioning Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Drug Repositioning Revenue Market Share by Company (2020-2025)
Table 41. Japan Drug Repositioning Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Drug Repositioning Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Aisa Drug Repositioning Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Aisa Drug Repositioning Revenue Market Share by Company (2020-2025)
Table 45. Southeast Aisa Drug Repositioning Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Aisa Drug Repositioning Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Drug Repositioning Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Drug Repositioning Revenue Market Share by Company (2020-2025)
Table 49. India Drug Repositioning Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Drug Repositioning Market Size by Application (2020-2025) & (US$ Million)
Table 51. Teva Company Details
Table 52. Teva Business Overview
Table 53. Teva Drug Repositioning Product
Table 54. Teva Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 55. Teva Recent Development
Table 56. Novartis Company Details
Table 57. Novartis Business Overview
Table 58. Novartis Drug Repositioning Product
Table 59. Novartis Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Mylan Company Details
Table 62. Mylan Business Overview
Table 63. Mylan Drug Repositioning Product
Table 64. Mylan Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 65. Mylan Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Drug Repositioning Product
Table 69. Johnson & Johnson Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Drug Repositioning Product
Table 74. Pfizer Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Bausch Health Company Details
Table 77. Bausch Health Business Overview
Table 78. Bausch Health Drug Repositioning Product
Table 79. Bausch Health Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 80. Bausch Health Recent Development
Table 81. GSK Company Details
Table 82. GSK Business Overview
Table 83. GSK Drug Repositioning Product
Table 84. GSK Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 85. GSK Recent Development
Table 86. ChemRar Group Company Details
Table 87. ChemRar Group Business Overview
Table 88. ChemRar Group Drug Repositioning Product
Table 89. ChemRar Group Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 90. ChemRar Group Recent Development
Table 91. Glenmark Company Details
Table 92. Glenmark Business Overview
Table 93. Glenmark Drug Repositioning Product
Table 94. Glenmark Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 95. Glenmark Recent Development
Table 96. Fujifilm Company Details
Table 97. Fujifilm Business Overview
Table 98. Fujifilm Drug Repositioning Product
Table 99. Fujifilm Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 100. Fujifilm Recent Development
Table 101. Dr. Reddy Company Details
Table 102. Dr. Reddy Business Overview
Table 103. Dr. Reddy Drug Repositioning Product
Table 104. Dr. Reddy Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 105. Dr. Reddy Recent Development
Table 106. R-Pharma Company Details
Table 107. R-Pharma Business Overview
Table 108. R-Pharma Drug Repositioning Product
Table 109. R-Pharma Revenue in Drug Repositioning Business (2020-2025) & (US$ Million)
Table 110. R-Pharma Recent Development
Table 111. Drug Repositioning Market Trends
Table 112. Drug Repositioning Market Drivers
Table 113. Drug Repositioning Market Challenges
Table 114. Drug Repositioning Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Repositioning Product Picture
Figure 2. Global Drug Repositioning Market Share by Type: 2024 VS 2031
Figure 3. Generic Drugs Features
Figure 4. Clinical Trial Failed Drugs Features
Figure 5. Global Drug Repositioning Market Share by Application: 2024 VS 2031
Figure 6. Cardiovascular Diseases
Figure 7. Mental Illness
Figure 8. Cancer
Figure 9. Others
Figure 10. Drug Repositioning Report Years Considered
Figure 11. Global Drug Repositioning Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Drug Repositioning Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drug Repositioning Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Drug Repositioning Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Drug Repositioning Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Drug Repositioning Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Drug Repositioning Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Southeast Aisa Drug Repositioning Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. India Drug Repositioning Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Drug Repositioning Market Share by Players in 2024
Figure 21. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Drug Repositioning Revenue in 2024
Figure 23. North America Drug Repositioning Market Share by Type (2020-2025)
Figure 24. North America Drug Repositioning Market Share by Application (2020-2025)
Figure 25. Europe Drug Repositioning Market Share by Type (2020-2025)
Figure 26. Europe Drug Repositioning Market Share by Application (2020-2025)
Figure 27. China Drug Repositioning Market Share by Type (2020-2025)
Figure 28. China Drug Repositioning Market Share by Application (2020-2025)
Figure 29. Japan Drug Repositioning Market Share by Type (2020-2025)
Figure 30. Japan Drug Repositioning Market Share by Application (2020-2025)
Figure 31. Southeast Aisa Drug Repositioning Market Share by Type (2020-2025)
Figure 32. Southeast Aisa Drug Repositioning Market Share by Application (2020-2025)
Figure 33. India Drug Repositioning Market Share by Type (2020-2025)
Figure 34. India Drug Repositioning Market Share by Application (2020-2025)
Figure 35. Teva Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 36. Novartis Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 37. Mylan Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 38. Johnson & Johnson Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 39. Pfizer Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 40. Bausch Health Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 41. GSK Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 42. ChemRar Group Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 43. Glenmark Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 44. Fujifilm Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 45. Dr. Reddy Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 46. R-Pharma Revenue Growth Rate in Drug Repositioning Business (2020-2025)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Drug Repositioning market size from 2025 to 2031?
The annual compound growth rate of the global Drug Repositioning market is 4.7% 2025 to 2031.
Which companies rank high in the global Drug Repositioning market?
What was the global market size of Drug Repositioning in 2031?
What was the global market size of Drug Repositioning in 2025?
Which region is expected to have the highest market share?
Related Reports
Global Drug Repositioning Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Drug Repositioning market size was US$ 30990 million in 2025 and is forecast to reach a readjusted size of US$ 42560 million by 2032 with a CAGR of 4.7% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 96
USD 4250.00
(Single User License)
Global Drug Repositioning Market Research Report 2026
The global Drug Repositioning market was valued at US$ 30990 million in 2025 and is anticipated to reach US$ 42560 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 120
USD 2900.00
(Single User License)
Drug Repositioning - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Repositioning was estimated to be worth US$ 30990 million in 2025 and is projected to reach US$ 42560 million, growing at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 112
USD 3950.00
(Single User License)
Global Drug Repositioning Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Repositioning market is projected to grow from US$ 28780 million in 2024 to US$ 40830 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-08
Pages: 136
USD 4900.00
(Single User License)
Drug Repositioning - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Repositioning was estimated to be worth US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 40830 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-04-16
Pages: 120
USD 3950.00
(Single User License)
Global Drug Repositioning Market Insights, Forecast to 2031
The global Drug Repositioning market is projected to grow from US$ 30990 million in 2025 to US$ 40830 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period.
Published Date: 2025-04-16
Pages: 136
USD 4900.00
(Single User License)
Global Drug Repositioning Market Research Report 2025
The global market for Drug Repositioning was valued at US$ 28780 million in the year 2024 and is projected to reach a revised size of US$ 40830 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published Date: 2025-04-16
Pages: 83
USD 2900.00
(Single User License)
Drug Repositioning- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Repositioning was estimated to be worth US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 39510 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 103
USD 3950.00
(Single User License)
Global Drug Repositioning Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Published Date: 2024-04-17
Pages: 152
USD 5600.00
(Single User License)
Global Drug Repositioning Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Published Date: 2024-04-16
Pages: 153
USD 5900.00
(Single User License)
Global Drug Repositioning Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Drug Repositioning market size was US$ 30990 million in 2025 and is forecast to reach a readjusted size of US$ 42560 million by 2032 with a CAGR of 4.7% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 96
USD 4250.00 (Single User License)Global Drug Repositioning Market Research Report 2026
The global Drug Repositioning market was valued at US$ 30990 million in 2025 and is anticipated to reach US$ 42560 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 120
USD 2900.00 (Single User License)Drug Repositioning - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Repositioning was estimated to be worth US$ 30990 million in 2025 and is projected to reach US$ 42560 million, growing at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 112
USD 3950.00 (Single User License)Global Drug Repositioning Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Repositioning market is projected to grow from US$ 28780 million in 2024 to US$ 40830 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-08
Pages: 136
USD 4900.00 (Single User License)Drug Repositioning - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Repositioning was estimated to be worth US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 40830 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-04-16
Pages: 120
USD 3950.00 (Single User License)Global Drug Repositioning Market Insights, Forecast to 2031
The global Drug Repositioning market is projected to grow from US$ 30990 million in 2025 to US$ 40830 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period.
Published: 2025-04-16
Pages: 136
USD 4900.00 (Single User License)Global Drug Repositioning Market Research Report 2025
The global market for Drug Repositioning was valued at US$ 28780 million in the year 2024 and is projected to reach a revised size of US$ 40830 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published: 2025-04-16
Pages: 83
USD 2900.00 (Single User License)Drug Repositioning- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Repositioning was estimated to be worth US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 39510 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 103
USD 3950.00 (Single User License)Global Drug Repositioning Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Published: 2024-04-17
Pages: 152
USD 5600.00 (Single User License)Global Drug Repositioning Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Published: 2024-04-16
Pages: 153
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now